Direct Medical Costs of Type 2 Diabetes in France: An Insurance Claims Database Analysis [0.03%]
法国2型糖尿病的直接医疗成本：保险索赔数据库分析
Bernard Charbonnel,Dominique Simon,Jean Dallongeville et al.
Bernard Charbonnel et al.
Objectives: Our objects was to estimate the direct healthcare costs of type 2 diabetes mellitus (T2DM) in France in 2013. Methods: Data...
Resources and Costs Associated with the Treatment of Advanced and Metastatic Gastric Cancer in the Mexican Public Sector: A Patient Chart Review [0.03%]
墨西哥公共部门晚期和转移性胃癌的治疗资源和成本：患者病历回顾
Miguel Quintana,José A Toriz,Diego Novick et al.
Miguel Quintana et al.
Background: Little evidence is available on the management and cost of treating patients with advanced or metastatic gastric cancer (GC). This study evaluates patient characteristics, treatment patterns, and resource util...
Economic Evaluation of Midazolam-Droperidol Combination, Versus Droperidol or Olanzapine for the Management of Acute Agitation in the Emergency Department: A Within-Trial Analysis [0.03%]
急诊科急性躁动患者使用咪达唑仑-氯普噻吨联合用药、单用氯普噻吨或奥氮平治疗的经济性评价：一项研究内分析
Celene Y L Yap,Ya-Seng Arthur Hsueh,Jonathan C Knott et al.
Celene Y L Yap et al.
Background: The combination of midazolam and droperidol has proven superior to droperidol or olanzapine monotherapy in the management of acute agitation in emergency departments (EDs). ...
Trevor Jozef Piatkiewicz,Janine Marie Traulsen,Tove Holm-Larsen
Trevor Jozef Piatkiewicz
Objective: Our objectives were to explore the changes in the level of interest in risk-sharing agreements (RSAs) in the EU during the last 15 years and the underlying reasons for these changes. ...
Cost of Intensive Care Treatment for Liver Disorders at Tertiary Care Level in India [0.03%]
印度三级医疗水平肝病重症监护治疗费用
Shankar Prinja,Pankaj Bahuguna,Ajay Duseja et al.
Shankar Prinja et al.
Background: Liver diseases contribute significantly to the health and economic burden globally. We undertook this study to assess the health system costs, out-of-pocket (OOP) expenditure and extent of financial risk prote...
Health-Related Quality of Life in Patients Treated with Continuous Ambulatory Peritoneal Dialysis and Automated Peritoneal Dialysis in Singapore [0.03%]
新加坡持续性腹膜透析及自动化腹膜透析患者的生活质量研究
F Yang,N Luo,T Lau et al.
F Yang et al.
Objective: This study aimed to compare the health-related quality of life (HRQOL) in patients with end-stage renal disease (ESRD) treated with continuous ambulatory peritoneal dialysis (CAPD) and automated peritoneal dial...
Does Methodological Guidance Produce Consistency? A Review of Methodological Consistency in Breast Cancer Utility Value Measurement in NICE Single Technology Appraisals [0.03%]
系统评价：英国NICE卫生技术评估中乳腺癌疾病预后效用值测量的规范化方法及一致性分析
Micah Rose,Stephen Rice,Dawn Craig
Micah Rose
Since 2004, National Institute for Health and Care Excellence (NICE) methodological guidance for technology appraisals has emphasised a strong preference for using the validated EuroQol 5-Dimensions (EQ-5D) quality-of-life instrument, measu...
Raise the Bar, Not the Threshold Value: Meeting Patient Preferences for Palliative and End-of-Life Care [0.03%]
顺应患者意愿提高 palliative 和 end-of-life 照护标准而不是治疗阈值
Nikki McCaffrey,Simon Eckermann
Nikki McCaffrey
Paula K Lorgelly
Paula K Lorgelly
Functional Status and Well-Being in People with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Compared with People with Multiple Sclerosis and Healthy Controls [0.03%]
与多发性硬化症患者和健康对照者相比肌痛性脑脊髓炎/慢性疲劳综合症患者的机能状态和幸福感如何
Caroline C Kingdon,Erinna W Bowman,Hayley Curran et al.
Caroline C Kingdon et al.
Background: People with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) continue to struggle to have their condition recognised as disabling in the face of public and professional prejudice and discrimination....